Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids
Qingda Meng, Shanshan Xie, G. Kenneth Gray, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003213-e003213
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 299
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
Luc Magré, Monique M.A. Verstegen, Sonja I. Buschow, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006290-e006290
Open Access | Times Cited: 59
Cancer organoid co-culture model system: Novel approach to guide precision medicine
Jin Yuan, Xiaoyang Li, Shengji Yu
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 54
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Newly developed 3D in vitro models to study tumor–immune interaction
Peiyuan Mu, Shujuan Zhou, Tao Lv, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 34
TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes
M Dezfulian, Tomasz Kula, Thomas Pranzatelli, et al.
Cell (2023) Vol. 186, Iss. 25, pp. 5569-5586.e21
Open Access | Times Cited: 24
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Yichen Zhu, Elliot Kang, Matthew Wilson, et al.
Organoids (2022) Vol. 1, Iss. 2, pp. 149-167
Open Access | Times Cited: 34
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22
Prostate organoids: emerging experimental tools for translational research
Michael L. Beshiri, Supreet Agarwal, Juan Juan Yin, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 19
Establishing conditions for the generation and maintenance of estrogen receptor-positive organoid models of breast cancer
Michael Oliphant, Dipikaa Akshinthala, Senthil K. Muthuswamy
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 7
A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses
Antonella Raffo‐Romero, Lydia Ziane-Chaouche, Sophie Salomé‐Desnoulez, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 6, pp. 100792-100792
Open Access | Times Cited: 7
Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment
Kalpana Ravi, Twinkle Jina Minette Manoharan, Kuei-Chun Wang, et al.
Biomaterials (2023) Vol. 305, pp. 122428-122428
Closed Access | Times Cited: 13
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 5
Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice
Kateryna Onyshchenko, Luo Ren, Elena Guffart, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 4
Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology
Jihao Xu, Minh Duc Pham, Vincenzo Corbo, et al.
Experimental & Molecular Medicine (2025)
Open Access
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients
Xiongfei Xu, Shiwei Guo, Haihui Gu, et al.
JCI Insight (2025) Vol. 10, Iss. 2
Open Access
The future of tumor organoids in precision therapy
Seok-Young Kim, Marc van de Wetering, Hans Clevers, et al.
Trends in cancer (2025)
Open Access
Patient-derived tumor organoids for cancer immunotherapy: culture techniques and clinical application
Ningning Yao, Na Jing, Jianzhong Lin, et al.
Investigational New Drugs (2025)
Open Access
Organoid co‐culture models of the tumor microenvironment promote precision medicine
Zhaoru Gu, Quanyou Wu, Bingqing Shang, et al.
Cancer Innovation (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application
Xu Wang, Zhengjie Dai, Xuan Lin, et al.
Cancer Letters (2024) Vol. 588, pp. 216741-216741
Closed Access | Times Cited: 3
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges
M M Rahman, Greg Wells, Juha Rantala, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 821-838
Open Access | Times Cited: 3
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
Zhilang Li, Lisha Ma, Zhaoya Gao, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 9
Open Access | Times Cited: 3
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment
Francesca Picca, Claudia Giannotta, Jiahao Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10823-10823
Open Access | Times Cited: 3
Immune organoid for cancer immunotherapy
Xiaohe Wang, Wuyin Wang, Zhi‐Jun Sun
Acta Pharmaceutica Sinica B (2025)
Open Access
Page 1 - Next Page

Scroll to top